Skip to main content
. 2017 Mar 13;8(21):34362–34373. doi: 10.18632/oncotarget.16156

Figure 5. Notch3 knockdown renders urothelial cancer cells sensitive to a 15-day treatment with cisplatin.

Figure 5

(A) Cell viability of T24 cells under different treatment was detected by CCK-8 assay. (B) To assess the formation of cisplatin-resistant colonies, T24 cells were either untreated (control) or treated with Notch3-shRNA alone, cisplatin alone, or cisplatin plus Notch3-shRNA, and cultured for 15 days.